UGGERI, MATTEO
UGGERI, MATTEO
Istituto di Tecnologie Biomediche - ITB
Molecular Mechanisms Involved in the B Cell Growth and Clonogenic Activity of HIV-1 Matrix Protein p17 Variants
2024 D'Ursi, Pasqualina; Rondina, Alessandro; Zani, Alberto; Uggeri, Matteo; Messali, Serena; Caruso, Arnaldo; Caccuri, Francesca
Germline NUP98 Variants in Two Siblings with a Rothmund–Thomson-Like Spectrum: Protein Functional Changes Predicted by Molecular Modeling
2023 Colombo, E. A.; Valiante, M.; Uggeri, M.; Orro, A.; Majore, S.; Grammatico, P.; Gentilini, D.; Finelli, P.; Gervasini, C.; D'Ursi, P.; Larizza, L.
Virtual Drug Repositioning as a Tool to Identify Natural Small Molecules That Synergize with Lumacaftor in F508del-CFTR Binding and Rescuing
2022 Fossa, P.; Uggeri, M.; Orro, A.; Urbinati, C.; Rondina, A.; Milanesi, M.; Pedemonte, N.; Pesce, E.; Padoan, R.; Ford, R. C.; Meng, X.; Rusnati, M.; D'Ursi, P.
Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin
2021 Caccuri, F.; D'Ursi, P.; Uggeri, M.; Bugatti, A.; Mazzuca, P.; Zani, A.; Filippini, F.; Salmona, M.; Ribatti, D.; Slevin, M.; Orro, A.; Lu, W.; Lio, P.; Gallo, R. C.; Caruso, A.
In silico drug repositioning on F508del-CFTR: A proof-of-concept study on the AIFA library
2021 Orro, A.; Uggeri, M.; Rusnati, M.; Urbinati, C.; Pedemonte, N.; Pesce, E.; Moscatelli, M.; Padoan, R.; Cichero, E.; Fossa, P.; D'Ursi, P.
Exploitation of a novel biosensor based on the full-length human F508de1-CFTR with computational studies, biochemical and biological assays for the characterization of a new Lumacaftor/Tezacaftor analogue
2019 D'Ursi, P; Uggeri, M; Urbinati, C; Millo, E; Paiardi, G; Milanesi, L; Ford, R C; Clews, J; Meng, X; Bergese, P; Ridolfi, A; Pedemonte, N; Fossa, P; Orro, A; Rusnati, M
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Molecular Mechanisms Involved in the B Cell Growth and Clonogenic Activity of HIV-1 Matrix Protein p17 Variants | 1-gen-2024 | D'Ursi, Pasqualina; Rondina, Alessandro; Zani, Alberto; Uggeri, Matteo; Messali, Serena; Caruso, Arnaldo; Caccuri, Francesca | |
| Germline NUP98 Variants in Two Siblings with a Rothmund–Thomson-Like Spectrum: Protein Functional Changes Predicted by Molecular Modeling | 1-gen-2023 | Colombo, E. A.; Valiante, M.; Uggeri, M.; Orro, A.; Majore, S.; Grammatico, P.; Gentilini, D.; Finelli, P.; Gervasini, C.; D'Ursi, P.; Larizza, L. | |
| Virtual Drug Repositioning as a Tool to Identify Natural Small Molecules That Synergize with Lumacaftor in F508del-CFTR Binding and Rescuing | 1-gen-2022 | Fossa, P.; Uggeri, M.; Orro, A.; Urbinati, C.; Rondina, A.; Milanesi, M.; Pedemonte, N.; Pesce, E.; Padoan, R.; Ford, R. C.; Meng, X.; Rusnati, M.; D'Ursi, P. | |
| Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin | 1-gen-2021 | Caccuri, F.; D'Ursi, P.; Uggeri, M.; Bugatti, A.; Mazzuca, P.; Zani, A.; Filippini, F.; Salmona, M.; Ribatti, D.; Slevin, M.; Orro, A.; Lu, W.; Lio, P.; Gallo, R. C.; Caruso, A. | |
| In silico drug repositioning on F508del-CFTR: A proof-of-concept study on the AIFA library | 1-gen-2021 | Orro, A.; Uggeri, M.; Rusnati, M.; Urbinati, C.; Pedemonte, N.; Pesce, E.; Moscatelli, M.; Padoan, R.; Cichero, E.; Fossa, P.; D'Ursi, P. | |
| Exploitation of a novel biosensor based on the full-length human F508de1-CFTR with computational studies, biochemical and biological assays for the characterization of a new Lumacaftor/Tezacaftor analogue | 1-gen-2019 | D'Ursi, P; Uggeri, M; Urbinati, C; Millo, E; Paiardi, G; Milanesi, L; Ford, R C; Clews, J; Meng, X; Bergese, P; Ridolfi, A; Pedemonte, N; Fossa, P; Orro, A; Rusnati, M |